title: A case of typhlitis developed after chemotherapy with irinotecan and Cisplatin in a patient with small cell lung carcinoma.
abstract: Typhlitis is a necrotizing colitis that usually occurs in neutropenic patients and develops most often in patients with hematologic malignancies such as leukemia and lymphoma. Typhlitis may proceed to bowel perforation, peritonitis and sepsis, which requires immediate treatment. Irinotecan is a semisynthetic analogue of the natural alkaloid camptothecin which prevents DNA from unwinding by inhibition of topoisomerase I. It is mainly used in colon cancer and small cell lung carcinoma (SCLC), of which the most common adverse effects are gastrointestinal toxicities. To the best of our knowledge, no case of typhlitis after chemotherapy with a standard dose of irinotecan in a solid tumor has been reported in the literature. We, herein, report the first case of typhlitis developed after chemotherapy combining irinotecan and cisplatin in a patient with SCLC.
authors.affiliation: Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Korea.
authors.forename: Eun Hye
authors.initials: EH
authors.lastname: Ji
authors.forename: Young Min
authors.initials: YM
authors.lastname: Kim
authors.forename: Soo Jeong
authors.initials: SJ
authors.lastname: Kim
authors.forename: Soo Jeong
authors.initials: SJ
authors.lastname: Yeom
authors.forename: Sung Eun
authors.initials: SE
authors.lastname: Ha
authors.forename: Hyeon Hui
authors.initials: HH
authors.lastname: Kang
authors.forename: Ji Young
authors.initials: JY
authors.lastname: Kang
authors.forename: Sang Haak
authors.initials: SH
authors.lastname: Lee
authors.forename: Hwa Sik
authors.initials: HS
authors.lastname: Moon